BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19487655)

  • 1. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
    Nishiyama S; Ito T; Misu T; Takahashi T; Kikuchi A; Suzuki N; Jin K; Aoki M; Fujihara K; Itoyama Y
    Neurology; 2009 Jun; 72(22):1960-1. PubMed ID: 19487655
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
    Lennon VA; Kryzer TJ; Pittock SJ; Verkman AS; Hinson SR
    J Exp Med; 2005 Aug; 202(4):473-7. PubMed ID: 16087714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity and heterogeneity in demyelinating disease.
    Compston A
    Brain; 2007 May; 130(Pt 5):1178-80. PubMed ID: 17472981
    [No Abstract]   [Full Text] [Related]  

  • 6. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
    Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
    Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS aquaporin-4 autoimmunity in children.
    McKeon A; Lennon VA; Lotze T; Tenenbaum S; Ness JM; Rensel M; Kuntz NL; Fryer JP; Homburger H; Hunter J; Weinshenker BG; Krecke K; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jul; 71(2):93-100. PubMed ID: 18509092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMO-IgG detected in CSF in seronegative neuromyelitis optica.
    Klawiter EC; Alvarez E; Xu J; Paciorkowski AR; Zhu L; Parks BJ; Cross AH; Naismith RT
    Neurology; 2009 Mar; 72(12):1101-3. PubMed ID: 19307546
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
    Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
    Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
    Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
    Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of chronic progressive myelopathy.
    Kim JS; Park YH; Kim SM; Kim SH; Park KS; Sung JJ; Lee KW
    Mult Scler; 2010 Oct; 16(10):1255-7. PubMed ID: 20798133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Weinshenker BG; Jacob A
    Neurology; 2007 Apr; 68(16):1326; author reply 1327. PubMed ID: 17438233
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuromyelitis optica preceded by brain demyelinating episode.
    Amemiya S; Hamamoto M; Kumagai T; Ueda M; Katayama Y; Tanaka K
    J Neuroimaging; 2009 Jul; 19(3):263-5. PubMed ID: 18681925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.